 |
- Susanne Barnett, Associate Professor (CHS)
Research Interests: Dr. Barnett's scholarship is motivated by identified areas of improvement in the classroom and within her clinical practice site. Her research relies on quality improvement and assurance processes to guide antimicrobial stewardship and teaching practices.
|
 |
- Eric Buxton, Clinical Professor and Chair
Professional Interests: Development, implementation and evaluation of continuing education offerings for individuals in the pharmaceutical industry.
|
 |
- Steven Ebert, Clinical Professor
Clinical Practice and Research Interests: Antimicrobial resistance, antimicrobial pharmacokinetics/ pharmacodynamics, and appropriate utilization of healthcare resources.
|
 |
- Casey Gallimore, Professor
-
|
 |
- Barry Gidal, Professor (CHS)
Clinical Practice: Neurology
Research Interests: Pharmacokinetics, pharmacodynamics, and the metabolic effects of anticonvulsant medications.
|
 |
- Lisa Holle, Professor (CHS)
Clinical Practice: UW Carbone Cancer Center: adult ambulatory oncology care
Research Interests: Patient-decision making, roles/value of oncology pharmacist, cannabis
|
 |
- Paul Hutson, Professor (CHS) | Center for Psychedelic Research and Education
Clinical Practice: Palliative Care; Oncology / Hematology.
Research Interests: Palliative care; Population pharmacokinetic modeling; Entheogens.
|
 |
- Mara Kieser, Professor (CHS)
Clinical Practice: Long Term Care.
Research Interests: Health Outcomes in long term care; Benefits of student clerkships.
|
 |
- Karen Kopacek, Associate Professor (CHS)
Clinical Practice: Cardiac Rehabilitation; Rural Health (acute care)
|
 |
- Marina Maes, Associate Professor (CHS)
Clinical Practice: Family Medicine/Ambulatory Care Clinic
Research Interests: Scholarship of teaching and learning (SoTL), evaluation of pharmacist services on clinical outcomes, expansion of reproductive health services and education
|
 |
- Amanda Margolis, Associate Professor (CHS)
Research Interests: Centralized Specialty Medication Management, Service implementation, Teaching and learning of evidence-based medicine
|
 |
- Beth Martin, Professor (CHS)
Clinical Interests: Community pharmacy practice. Older adult medicines and reducing falls risk.
Research Interests: Evaluate the effectiveness of educational methodologies to enhance pharmacist, student or patient learning and confidence, and the degree to which performance-based abilities are transferred from the learning environment to the real world setting.
|
 |
- Michael Pitterle, (None)
Research Interests: Development and evaluation of computer applications in pharmacy student education and practice.
|
 |
- Andrea Porter, Professor (CHS) and Chair
Clinical Practice: Anticoagulation
Research Interests: Educational-based scholarship, particularly educational innovation and teaching methods, as well as clinical research involving anticoagulation
|
 |
- Edward Portillo, Associate Professor (CHS)
Clinical Practice: Primary Care/Ambulatory Care Clinic Practice
Research Interests: Evaluation and expansion of interprofessional service models using dissemination science to incorporate pharmacists as patient care providers. Education-based research involving evaluation of thematic curricular pathways to best position students for success post-graduation.
|
 |
- Trisha Seys Ranola, Clinical Assistant Professor
Clinical practice: Interdisciplinary team geriatric medicine; diabetes; cardiac: hypertension, lipids, heart failure; anticoagulation; anemia; polypharmacy reduction
|
 |
- Denise Walbrandt Pigarelli, Associate Professor (CHS)
Clinical Practice: Diabetes.
Research Interests: Clinical and quality of life outcomes of drug therapy and pharmaceutical care. Academic research interests include outcomes related to instructional design and assessment
|
 |
- Cody Wenthur, Associate Professor (Drug Action)| Wenthur Lab Website | Wisconsin Opioid Overdose Resource Center (WOORC)
Research Interests: Synaptic plasticity in substance use and major depressive disorders; Development of antibodies against cannabinoids, opioids, sedative-hypnotics, and classical psychedelics; Immunologic biomarkers of drug use; Implementation of novel psychiatric treatments, including vaccine-based approaches and medication-assisted psychotherapy
|